ClosedPublished 17 Sep 2026
Lisata Therapeutics, Inc. /
Marea Therapeutics, Inc.
Lisata Therapeutics, Inc. completed its deal for Marea Therapeutics, Inc.
01 / BuyerLisata Therapeutics, Inc.
02 / TargetMarea Therapeutics, Inc.
Source for the buyer and target: Lisata Therapeutics, Inc.
For the buyer and target.
“On September 17, 2026, Lisata Therapeutics, Inc., a Delaware corporation (the “ Company” or “Lisata”), acquired Marea Therapeutics, Inc., a Delaware corporation (“Marea”), in accordance with the terms of the Agreement and Plan of Merger, dated September 17, 2026 (the “Merger Agreement”), by and among the Company, Mariner Merger Sub I, Inc., a Delaware corporation and a wholly owned subsidiary of the Company (“ First Merger Sub”), Mariner Merger Sub II, LLC, a Delaware limited liability company and wholly owned subsidiary of the Company (“Second Merger Sub”), and Marea.”
Published 17 Sep 2026
Open the sourceWhat happened
The deal for Marea Therapeutics, Inc. has closed, with Lisata Therapeutics, Inc. as the buyer. [01]
The filing from Lisata Therapeutics, Inc. is dated Sept. 17, 2026. [01]
The source
Everything on this page comes from the source below, quoted word for word.
01
Source · Lisata Therapeutics, Inc.
Lisata Therapeutics, Inc. completed its deal for Marea Therapeutics, Inc.
This document is the source for the companies, stage and people on this page.
Open the sourceTimeline
Every date the source states, in order, each with the words it comes from. Anything marked ahead is a target the source gives, not something that has happened.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Get ProAlready a member? Sign in
Pro is open to everyone.
By email · Weekly